Acute Hepatic Porphyria Market refers to a family of rare genetic metabolic disorders characterized by life-threatening attacks and, for some, debilitating chronic symptoms. In 2025, the treatment landscape for AHP is witnessing a significant shift from reactive crisis management toward proactive, long-term therapeutic prevention. https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/